Adv Cancer Res Advances in Cancer Research
Am J Pathol The American Journal of Pathology
Am J Physiol Cell Physiol American Journal of Physiology
Annu Rev Biomed Eng Annual Review of Biomedical Engineering
Breast Cancer Res Treat Breast Cancer Research and Treatment
Cancer J Clin A Cancer Journal for Clinicians
Cancer Lett Cancer Letters
Cancer Res Cancer Research
Cancer Sci Cancer Science
Cell Death Differ Cell Death & Differentiation
Cell Growth Differ Cell Growth & Differentiation
Cell Oncol Cellular Oncology
Clin Cancer Res Clinical Cancer Research
EMBO The EMBO Journal
Genes Dev Genes & Development
Infect Immun Infection and Immunity
Int J Biochem Cell Biol The International Journal of Biochemistry & Cell
Biology
Int J Cancer International Journal of Cancer
117
J Biol Chem The Journal of Biological Chemistry
J Cell Biochem Journal of Cellular Biochemistry
J Cell Sci Journal of Cell Science
J Clin Invest The Journal of Clinical Investigation
J Dermatol Sci Journal of Dermatological Science
J Exp Med The Journal of Experimental Medicine
J Natl Cancer Inst Journal of the National Cancer Institute
J Pathol The Journal of Pathology
J Proteomics Journal of Proteomics
Mol Cell Biol Molecular and Cellular Biology
Mol Cell Proteomics Molecular & Cellular Proteomics
N Engl J Med The New England Journal of Medicine
Nat Biotechnol Nature Biotechnology
Nat Cell Biol Nature Cell Biology
Nat Commun Nature Communications
Nat Med Nature Medicine
Nat Rev Cancer Nature Reviews Cancer
Nat Rev Drug Discov Nature Reviews Drug Discovery
Nat Rev Genet Nature Reviews Genetics
Nat Rev Mol Cell Biol Nature Reviews Molecular Cell Biology
118 REFERENCES
1. Gupta, G.P., and Massague, J. 2006. Cancer metastasis: building a
framework. Cell 127:679-695.
2. Valastyan, S., and Weinberg, R.A. 2011. Tumor metastasis: molecular
insights and evolving paradigms. Cell 147:275-292.
3. Wirtz, D., Konstantopoulos, K., and Searson, P.C. 2011. The physics of
cancer: the role of physical interactions and mechanical forces in metastasis. Nat Rev Cancer 11:512-522.
4. Joyce, J.A., and Pollard, J.W. 2009. Microenvironmental regulation of
metastasis. Nat Rev Cancer 9:239-252.
5. Taddei, M.L., Giannoni, E., Fiaschi, T., and Chiarugi, P. 2012. Anoikis: an
emerging hallmark in health and diseases. J Pathol 226:380-393.
6. Luzzi, K.J., MacDonald, I.C., Schmidt, E.E., Kerkvliet, N., Morris, V.L.,
Chambers, A.F., and Groom, A.C. 1998. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153:865-873.
7. Psaila, B., and Lyden, D. 2009. The metastatic niche: adapting the foreign
soil. Nat Rev Cancer 9:285-293.
8. Cavallaro, U., and Christofori, G. 2004. Cell adhesion and signalling by
119
9. Polyak, K., and Weinberg, R.A. 2009. Transitions between epithelial and
mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev
Cancer 9:265-273.
10. Massague, J., Blain, S.W., and Lo, R.S. 2000. TGFbeta signaling in
growth control, cancer, and heritable disorders. Cell 103:295-309.
11. Massague, J., Seoane, J., and Wotton, D. 2005. Smad transcription
factors. Genes Dev 19:2783-2810.
12. Brabletz, T. 2012. To differentiate or not--routes towards metastasis. Nat
Rev Cancer 12:425-436.
13. Sethi, N., and Kang, Y. 2011. Unravelling the complexity of metastasis -
molecular understanding and targeted therapies. Nat Rev Cancer 11:735- 748.
14. Carmeliet, P., and Jain, R.K. 2011. Principles and mechanisms of vessel
normalization for cancer and other angiogenic diseases. Nat Rev Drug
Discov 10:417-427.
15. Egeblad, M., and Werb, Z. 2002. New functions for the matrix
metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174.
16. Nguyen, D.X., Bos, P.D., and Massague, J. 2009. Metastasis: from
dissemination to organ-specific colonization. Nat Rev Cancer 9:274-284.
17. Avraamides, C.J., Garmy-Susini, B., and Varner, J.A. 2008. Integrins in
120
18. Desgrosellier, J.S., and Cheresh, D.A. 2010. Integrins in cancer: biological
implications and therapeutic opportunities. Nat Rev Cancer 10:9-22.
19. Guo, W., Pylayeva, Y., Pepe, A., Yoshioka, T., Muller, W.J., Inghirami, G.,
and Giancotti, F.G. 2006. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126:489-502.
20. Bingle, L., Brown, N.J., and Lewis, C.E. 2002. The role of tumour-
associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196:254-265.
21. Roussos, E.T., Condeelis, J.S., and Patsialou, A. 2011. Chemotaxis in
cancer. Nat Rev Cancer 11:573-587.
22. Gocheva, V., Wang, H.W., Gadea, B.B., Shree, T., Hunter, K.E., Garfall,
A.L., Berman, T., and Joyce, J.A. 2010. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev 24:241-255.
23. Gocheva, V., Zeng, W., Ke, D., Klimstra, D., Reinheckel, T., Peters, C.,
Hanahan, D., and Joyce, J.A. 2006. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 20:543-556.
24. Guo, W., and Giancotti, F.G. 2004. Integrin signalling during tumour
progression. Nat Rev Mol Cell Biol 5:816-826.
25. Pylayeva-Gupta, Y., Grabocka, E., and Bar-Sagi, D. 2011. RAS
121
26. Scheel, C., and Weinberg, R.A. 2012. Cancer stem cells and epithelial-
mesenchymal transition: concepts and molecular links. Semin Cancer Biol 22:396-403.
27. Napier, S.L., Healy, Z.R., Schnaar, R.L., and Konstantopoulos, K. 2007.
Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44v and alternative sialofucosylated selectin ligands. J Biol Chem 282:3433-3441.
28. Thomas, S.N., Schnaar, R.L., and Konstantopoulos, K. 2009.
Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells. Am J Physiol Cell Physiol 296:C505-513.
29. Thomas, S.N., Zhu, F., Schnaar, R.L., Alves, C.S., and Konstantopoulos,
K. 2008. Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem 283:15647-15655.
30. Konstantopoulos, K., and Thomas, S.N. 2009. Cancer cells in transit: the
vascular interactions of tumor cells. Annu Rev Biomed Eng 11:177-202.
31. Gay, L.J., and Felding-Habermann, B. 2011. Contribution of platelets to
tumour metastasis. Nat Rev Cancer 11:123-134.
32. Thiery, J.P., Acloque, H., Huang, R.Y., and Nieto, M.A. 2009. Epithelial-
122
33. Cieply, B., Farris, J., Denvir, J., Ford, H.L., and Frisch, S.M. 2013.
Epithelial-Mesenchymal Transition and Tumor Suppression Are Controlled by a Reciprocal Feedback Loop between ZEB1 and Grainyhead-like-2.
Cancer Res 73:6299-6309.
34. Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E.,
Spaderna, S., and Brabletz, T. 2008. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9:582-589.
35. Park, S.M., Gaur, A.B., Lengyel, E., and Peter, M.E. 2008. The miR-200
family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22:894-907.
36. Solanas, G., Porta-de-la-Riva, M., Agusti, C., Casagolda, D., Sanchez-
Aguilera, F., Larriba, M.J., Pons, F., Peiro, S., Escriva, M., Munoz, A., et al. 2008. E-cadherin controls beta-catenin and NF-kappaB transcriptional activity in mesenchymal gene expression. J Cell Sci 121:2224-2234.
37. Buijs, J.T., Henriquez, N.V., van Overveld, P.G., van der Horst, G., Que,
I., Schwaninger, R., Rentsch, C., Ten Dijke, P., Cleton-Jansen, A.M., Driouch, K., et al. 2007. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Cancer Res
123
38. Sohara, Y., Shimada, H., and DeClerck, Y.A. 2005. Mechanisms of bone
invasion and metastasis in human neuroblastoma. Cancer Lett 228:203- 209.
39. Mundy, G.R. 2002. Metastasis to bone: causes, consequences and
therapeutic opportunities. Nat Rev Cancer 2:584-593.
40. Erler, J.T., Bennewith, K.L., Cox, T.R., Lang, G., Bird, D., Koong, A., Le,
Q.T., and Giaccia, A.J. 2009. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.
Cancer Cell 15:35-44.
41. Weis, S.M., and Cheresh, D.A. 2011. Tumor angiogenesis: molecular
pathways and therapeutic targets. Nat Med 17:1359-1370.
42. Mehlen, P., and Puisieux, A. 2006. Metastasis: a question of life or death.
Nat Rev Cancer 6:449-458.
43. Stupack, D.G., Teitz, T., Potter, M.D., Mikolon, D., Houghton, P.J., Kidd,
V.J., Lahti, J.M., and Cheresh, D.A. 2006. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 439:95-99.
44. Martinez, R., Setien, F., Voelter, C., Casado, S., Quesada, M.P.,
Schackert, G., and Esteller, M. 2007. CpG island promoter
hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. Carcinogenesis 28:1264- 1268.
124
45. Stafford, L.J., Vaidya, K.S., and Welch, D.R. 2008. Metastasis
suppressors genes in cancer. Int J Biochem Cell Biol 40:874-891.
46. Smith, S.C., and Theodorescu, D. 2009. Learning therapeutic lessons
from metastasis suppressor proteins. Nat Rev Cancer 9:253-264.
47. Steeg, P.S., Bevilacqua, G., Kopper, L., Thorgeirsson, U.P., Talmadge,
J.E., Liotta, L.A., and Sobel, M.E. 1988. Evidence for a novel gene
associated with low tumor metastatic potential. J Natl Cancer Inst 80:200- 204.
48. Baba, H., Urano, T., Okada, K., Furukawa, K., Nakayama, E., Tanaka, H.,
Iwasaki, K., and Shiku, H. 1995. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line. Cancer Res 55:1977-1981.
49. Welch, D.R., Chen, P., Miele, M.E., McGary, C.T., Bower, J.M.,
Stanbridge, E.J., and Weissman, B.E. 1994. Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene 9:255-262.
50. Dong, J.T., Lamb, P.W., Rinker-Schaeffer, C.W., Vukanovic, J., Ichikawa,
T., Isaacs, J.T., and Barrett, J.C. 1995. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268:884-886.
51. Yoshida, B.A., Dubauskas, Z., Chekmareva, M.A., Christiano, T.R.,
125
protein kinase kinase 4/stress-activated protein/Erk kinase 1
(MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res 59:5483-5487.
52. Valastyan, S., Reinhardt, F., Benaich, N., Calogrias, D., Szasz, A.M.,
Wang, Z.C., Brock, J.E., Richardson, A.L., and Weinberg, R.A. 2009. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.
Cell 137:1032-1046.
53. Balkwill, F. 2004. The significance of cancer cell expression of the
chemokine receptor CXCR4. Semin Cancer Biol 14:171-179.
54. Murakami, T., Cardones, A.R., and Hwang, S.T. 2004. Chemokine
receptors and melanoma metastasis. J Dermatol Sci 36:71-78.
55. Amersi, F.F., Terando, A.M., Goto, Y., Scolyer, R.A., Thompson, J.F.,
Tran, A.N., Faries, M.B., Morton, D.L., and Hoon, D.S. 2008. Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clin Cancer Res 14:638-645.
56. Murakami, T., Cardones, A.R., Finkelstein, S.E., Restifo, N.P., Klaunberg,
B.A., Nestle, F.O., Castillo, S.S., Dennis, P.A., and Hwang, S.T. 2003. Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med 198:1337-1347.
57. Wiley, H.E., Gonzalez, E.B., Maki, W., Wu, M.T., and Hwang, S.T. 2001.
Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 93:1638-1643.
126
58. Takanami, I. 2003. Overexpression of CCR7 mRNA in nonsmall cell lung
cancer: correlation with lymph node metastasis. Int J Cancer 105:186-189.
59. Mashino, K., Sadanaga, N., Yamaguchi, H., Tanaka, F., Ohta, M.,
Shibuta, K., Inoue, H., and Mori, M. 2002. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 62:2937-2941.
60. Minn, A.J., Gupta, G.P., Siegel, P.M., Bos, P.D., Shu, W., Giri, D.D., Viale,
A., Olshen, A.B., Gerald, W.L., and Massague, J. 2005. Genes that mediate breast cancer metastasis to lung. Nature 436:518-524.
61. Padua, D., Zhang, X.H., Wang, Q., Nadal, C., Gerald, W.L., Gomis, R.R.,
and Massague, J. 2008. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133:66-77.
62. Bos, P.D., Zhang, X.H., Nadal, C., Shu, W., Gomis, R.R., Nguyen, D.X.,
Minn, A.J., van de Vijver, M.J., Gerald, W.L., Foekens, J.A., et al. 2009. Genes that mediate breast cancer metastasis to the brain. Nature 459:1005-1009.
63. Tabaries, S., Dong, Z., Annis, M.G., Omeroglu, A., Pepin, F., Ouellet, V.,
Russo, C., Hassanain, M., Metrakos, P., Diaz, Z., et al. 2011. Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Oncogene 30:1318-1328.
127
64. Weilbaecher, K.N., Guise, T.A., and McCauley, L.K. 2011. Cancer to
bone: a fatal attraction. Nat Rev Cancer 11:411-425.
65. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., and Forman, D.
2011. Global cancer statistics. CA Cancer J Clin 61:69-90.
66. Siegel, R., Naishadham, D., and Jemal, A. 2013. Cancer statistics, 2013.
CA Cancer J Clin 63:11-30.
67. Desantis, C., Ma, J., Bryan, L., and Jemal, A. 2013. Breast cancer
statistics, 2013. CA Cancer J Clin.
68. Husemann, Y., Geigl, J.B., Schubert, F., Musiani, P., Meyer, M., Burghart,
E., Forni, G., Eils, R., Fehm, T., Riethmuller, G., et al. 2008. Systemic spread is an early step in breast cancer. Cancer Cell 13:58-68.
69. Liotta, L.A., and Kohn, E. 2004. Anoikis: cancer and the homeless cell.
Nature 430:973-974.
70. Douma, S., Van Laar, T., Zevenhoven, J., Meuwissen, R., Van Garderen,
E., and Peeper, D.S. 2004. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430:1034-1039.
71. Chambers, A.F., Groom, A.C., and MacDonald, I.C. 2002. Dissemination
and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563-572.
72. Steeg, P.S. 2003. Metastasis suppressors alter the signal transduction of
cancer cells. Nat Rev Cancer 3:55-63.
73. Phillips, K.K., Welch, D.R., Miele, M.E., Lee, J.H., Wei, L.L., and
128
metastasis following the introduction of human chromosome 11. Cancer
Res 56:1222-1227.
74. Dorudi, S., Sheffield, J.P., Poulsom, R., Northover, J.M., and Hart, I.R.
1993. E-cadherin expression in colorectal cancer. An
immunocytochemical and in situ hybridization study. Am J Pathol 142:981- 986.
75. Kashima, T., Nakamura, K., Kawaguchi, J., Takanashi, M., Ishida, T.,
Aburatani, H., Kudo, A., Fukayama, M., and Grigoriadis, A.E. 2003. Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo. Int J Cancer 104:147-154.
76. Kallakury, B.V., Yang, F., Figge, J., Smith, K.E., Kausik, S.J., Tacy, N.J.,
Fisher, H.A., Kaufman, R., Figge, H., and Ross, J.S. 1996. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy. Cancer 78:1461-1469.
77. Rodrigues, S., De Wever, O., Bruyneel, E., Rooney, R.J., and Gespach,
C. 2007. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis. Oncogene 26:5615- 5625.
78. Goodison, S., Yuan, J., Sloan, D., Kim, R., Li, C., Popescu, N.C., and
Urquidi, V. 2005. The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res 65:6042-6053.
129
79. Guan, R.J., Ford, H.L., Fu, Y., Li, Y., Shaw, L.M., and Pardee, A.B. 2000.
Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60:749-755.
80. Fujita, H., Okada, F., Hamada, J., Hosokawa, M., Moriuchi, T., Koya, R.C.,
and Kuzumaki, N. 2001. Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect. Int J Cancer 93:773-780.
81. Hickson, J.A., Huo, D., Vander Griend, D.J., Lin, A., Rinker-Schaeffer,
C.W., and Yamada, S.D. 2006. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer
Res 66:2264-2270.
82. Vander Griend, D.J., Kocherginsky, M., Hickson, J.A., Stadler, W.M., Lin,
A., and Rinker-Schaeffer, C.W. 2005. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-
terminal kinase kinases JNKK1/MKK4 and MKK7. Cancer Res 65:10984- 10991.
83. Agou, F., Raveh, S., and Veron, M. 2000. The binding mode of human
nucleoside diphosphate kinase B to single-strand DNA. J Bioenerg
Biomembr 32:285-292.
84. Singh, L.S., Berk, M., Oates, R., Zhao, Z., Tan, H., Jiang, Y., Zhou, A.,
130
protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer. J Natl Cancer Inst 99:1313-1327.
85. Gildea, J.J., Seraj, M.J., Oxford, G., Harding, M.A., Hampton, G.M.,
Moskaluk, C.A., Frierson, H.F., Conaway, M.R., and Theodorescu, D. 2002. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 62:6418-6423.
86. Fu, Z., Smith, P.C., Zhang, L., Rubin, M.A., Dunn, R.L., Yao, Z., and
Keller, E.T. 2003. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 95:878-889.
87. Gautam, A., Li, Z.R., and Bepler, G. 2003. RRM1-induced metastasis
suppression through PTEN-regulated pathways. Oncogene 22:2135-2142.
88. Lin, X., and Gelman, I.H. 1997. Reexpression of the major protein kinase
C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis. Cancer Res 57:2304-2312.
89. Khokha, R., Waterhouse, P., Yagel, S., Lala, P.K., Overall, C.M., Norton,
G., and Denhardt, D.T. 1989. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 243:947- 950.
90. Thiery, J.P. 2002. Epithelial-mesenchymal transitions in tumour
progression. Nat Rev Cancer 2:442-454.
91. Bandyopadhyay, S., Pai, S.K., Hirota, S., Hosobe, S., Takano, Y., Saito,
131
of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 23:5675-5681.
92. Hartsough, M.T., Clare, S.E., Mair, M., Elkahloun, A.G., Sgroi, D.,
Osborne, C.K., Clark, G., and Steeg, P.S. 2001. Elevation of breast
carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Cancer Res 61:2320-2327.
93. Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz, L.A.,
Jr., and Kinzler, K.W. 2013. Cancer genome landscapes. Science 339:1546-1558.
94. 2012. Comprehensive molecular portraits of human breast tumours.
Nature 490:61-70.
95. Stephens, P.J., Tarpey, P.S., Davies, H., Van Loo, P., Greenman, C.,
Wedge, D.C., Nik-Zainal, S., Martin, S., Varela, I., Bignell, G.R., et al. 2012. The landscape of cancer genes and mutational processes in breast cancer. Nature 486:400-404.
96. Montagner, M., Enzo, E., Forcato, M., Zanconato, F., Parenti, A.,
Rampazzo, E., Basso, G., Leo, G., Rosato, A., Bicciato, S., et al. 2012. SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature 487:380-384.
97. Chen, D., Sun, Y., Wei, Y., Zhang, P., Rezaeian, A.H., Teruya-Feldstein,
132
cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nat Med 18:1511-1517.
98. Steeg, P.S. 2006. Tumor metastasis: mechanistic insights and clinical
challenges. Nat Med 12:895-904.
99. Santner, S.J., Dawson, P.J., Tait, L., Soule, H.D., Eliason, J., Mohamed,
A.N., Wolman, S.R., Heppner, G.H., and Miller, F.R. 2001. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat 65:101-110.
100. Strickland, L.B., Dawson, P.J., Santner, S.J., and Miller, F.R. 2000. Progression of premalignant MCF10AT generates heterogeneous malignant variants with characteristic histologic types and
immunohistochemical markers. Breast Cancer Res Treat 64:235-240. 101. Tang, B., Vu, M., Booker, T., Santner, S.J., Miller, F.R., Anver, M.R., and
Wakefield, L.M. 2003. TGF-beta switches from tumor suppressor to
prometastatic factor in a model of breast cancer progression. J Clin Invest 112:1116-1124.
102. Oncomine™ (Compendia Bioscience, Ann Arbor, MI) was used for analysis and visualization.
103. Gyorffy, B., Lanczky, A., Eklund, A.C., Denkert, C., Budczies, J., Li, Q., and Szallasi, Z. 2010. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 123:725-731.
133
104. Uhlen, M., Bjorling, E., Agaton, C., Szigyarto, C.A., Amini, B., Andersen, E., Andersson, A.C., Angelidou, P., Asplund, A., Asplund, C., et al. 2005. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 4:1920-1932.
105. Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E., Jonasson, K., Forsberg, M., Zwahlen, M., Kampf, C., Wester, K., Hober, S., et al. 2010. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol
28:1248-1250.
106. Thomassen, M., Tan, Q., and Kruse, T.A. 2009. Gene expression meta- analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis. Breast Cancer Res Treat 113:239-249.
107. Tam, C.W., Liu, V.W., Leung, W.Y., Yao, K.M., and Shiu, S.Y. 2008. The autocrine human secreted PDZ domain-containing protein 2 (sPDZD2) induces senescence or quiescence of prostate, breast and liver cancer cells via transcriptional activation of p53. Cancer Lett 271:64-80.
108. Boye, K., and Maelandsmo, G.M. 2010. S100A4 and metastasis: a small actor playing many roles. Am J Pathol 176:528-535.
109. C, E.L.N., Grum-Schwensen, B., Mansouri, A., Grigorian, M., Santoni- Rugiu, E., Hansen, T., Kriajevska, M., Schafer, B.W., Heizmann, C.W., Lukanidin, E., et al. 2004. Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) gene. Oncogene 23:3670-3680.
134
110. Weinstock, P.H., Bisgaier, C.L., Aalto-Setala, K., Radner, H.,
Ramakrishnan, R., Levak-Frank, S., Essenburg, A.D., Zechner, R., and Breslow, J.L. 1995. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J Clin Invest 96:2555-2568.
111. Coleman, T., Seip, R.L., Gimble, J.M., Lee, D., Maeda, N., and
Semenkovich, C.F. 1995. COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated
triglycerides and impaired enzyme activity. J Biol Chem 270:12518-12525. 112. Buhman, K.K., Accad, M., Novak, S., Choi, R.S., Wong, J.S., Hamilton,
R.L., Turley, S., and Farese, R.V., Jr. 2000. Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice.
Nat Med 6:1341-1347.
113. Morrison, G., Kilanowski, F., Davidson, D., and Dorin, J. 2002.
Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect Immun 70:3053-3060.
114. Moser, C., Weiner, D.J., Lysenko, E., Bals, R., Weiser, J.N., and Wilson, J.M. 2002. beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun 70:3068-3072.
135
115. Hansen, C.G., Shvets, E., Howard, G., Riento, K., and Nichols, B.J. 2013. Deletion of cavin genes reveals tissue-specific mechanisms for
morphogenesis of endothelial caveolae. Nat Commun 4:1831.
116. Hansen, C.G., Bright, N.A., Howard, G., and Nichols, B.J. 2009. SDPR induces membrane curvature and functions in the formation of caveolae.
Nat Cell Biol 11:807-814.
117. Parton, R.G., and del Pozo, M.A. 2013. Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol 14:98-112. 118. Parton, R.G., and Simons, K. 2007. The multiple faces of caveolae. Nat
Rev Mol Cell Biol 8:185-194.
119. Li, X., Jia, Z., Shen, Y., Ichikawa, H., Jarvik, J., Nagele, R.G., and Goldberg, G.S. 2008. Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate. Cancer Sci 99:1326-1333.
120. Bai, L., Deng, X., Li, Q., Wang, M., An, W., Deli, A., Gao, Z., Xie, Y., Dai, Y., and Cong, Y.S. 2012. Down-regulation of the cavin family proteins in breast cancer. J Cell Biochem 113:322-328.
121. Altintas, D.M., Allioli, N., Decaussin, M., de Bernard, S., Ruffion, A., Samarut, J., and Vlaeminck-Guillem, V. 2013. Differentially expressed androgen-regulated genes in androgen-sensitive tissues reveal potential biomarkers of early prostate cancer. PLoS One 8:e66278.
136
122. Gianazza, E., Chinello, C., Mainini, V., Cazzaniga, M., Squeo, V., Albo, G., Signorini, S., Di Pierro, S.S., Ferrero, S., Nicolardi, S., et al. 2012. Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors. J Proteomics 76 Spec No.:125-140. 123. Gustincich, S., Vatta, P., Goruppi, S., Wolf, M., Saccone, S., Della Valle,
G., Baggiolini, M., and Schneider, C. 1999. The human serum deprivation response gene (SDPR) maps to 2q32-q33 and codes for a
phosphatidylserine-binding protein. Genomics 57:120-129.
124. Friedrich, K., Weber, T., Scheithauer, J., Meyer, W., Haroske, G., Kunze, K.D., and Baretton, G. 2008. Chromosomal genotype in breast cancer progression: comparison of primary and secondary manifestations. Cell
Oncol 30:39-50.
125. Gustincich, S., and Schneider, C. 1993. Serum deprivation response gene is induced by serum starvation but not by contact inhibition. Cell Growth
Differ 4:753-760.
126. Tenta, R., Katopodis, H., Chatziioannou, A., Pilalis, E., Calvo, E., Luu-The, V., Labrie, F., Kolisis, F., and Koutsilieris, M. 2007. Microarray analysis of survival pathways in human PC-3 prostate cancer cells. Cancer Genomics
Proteomics 4:309-318.
127. Debnath, J., Muthuswamy, S.K., and Brugge, J.S. 2003. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three- dimensional basement membrane cultures. Methods 30:256-268.
137
128. Li, L.C., and Dahiya, R. 2002. MethPrimer: designing primers for methylation PCRs. Bioinformatics 18:1427-1431.
129. Stewart, S.A., Dykxhoorn, D.M., Palliser, D., Mizuno, H., Yu, E.Y., An, D.S., Sabatini, D.M., Chen, I.S., Hahn, W.C., Sharp, P.A., et al. 2003. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9:493-501.
130. Levine, A.J., and Oren, M. 2009. The first 30 years of p53: growing ever more complex. Nat Rev Cancer 9:749-758.
131. Vousden, K.H., and Lane, D.P. 2007. p53 in health and disease. Nat Rev
Mol Cell Biol 8:275-283.
132. Youle, R.J., and Strasser, A. 2008. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47-59.
133. Ley, R., Ewings, K.E., Hadfield, K., and Cook, S.J. 2005. Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. Cell Death
Differ 12:1008-1014.
134. Weston, C.R., Balmanno, K., Chalmers, C., Hadfield, K., Molton, S.A., Ley, R., Wagner, E.F., and Cook, S.J. 2003. Activation of ERK1/2 by deltaRaf-1:ER* represses Bim expression independently of the JNK or PI3K pathways. Oncogene 22:1281-1293.
135. Chen, C., Edelstein, L.C., and Gelinas, C. 2000. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol
138
136. Bentires-Alj, M., Dejardin, E., Viatour, P., Van Lint, C., Froesch, B., Reed, J.C., Merville, M.P., and Bours, V. 2001. Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines.
Oncogene 20:2805-2813.
137. Thornberry, N.A. 1999. Caspases: a decade of death research. Cell Death